Rejuvenation Technologies Inc.
mRNA therapeutics to extend healthspan entering clinical trials
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Reverses 10 years of telomere shortening with a single dose. Preclinical efficacy in fibrotic liver and lung disease. Entering IND-enabling. 50+ granted patents, 7 patent families. FDA INTERACT cleared.
- Website
- rejuvenationtech.com
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2018
- Team
- 7 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run rejuvenationtech.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Rejuvenation Technologies Inc. across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Rejuvenation Technologies Inc.'s standing on Labspie, or a simple badge. Both link to this profile and update themselves.
